$SPCXBearishMed

That Didn't Take Long: SpaceX Earned Its First Wall Street Sell Rating Less Than an Hour After Trading Began

SpaceX began trading on June 12 after raising $75 billion in the largest IPO on record, valuing the company at about $2.1 trillion. About 20 minutes later, CFRA analyst Keith Snyder issued SpaceX its first Wall Street sell rating, setting a $115 target versus a $160.95 close, implying up to a 29% drop. CFRA cited Starship execution and uncertainty around xAI growth.

7/10
6/10
Med
Bearish
Within ~1 hour of first trade after the IPO
Sell-side caution aligns with a risk-off reaction to execution/valuation concerns

The article’s actionable catalyst is an immediate first sell rating with a large implied downside, which can drive early positioning and volatility around the IPO.

CFRA initiated a first sell rating on SpaceX shortly after its Nasdaq IPO, targeting $115 versus a $160.95 close and citing Starship and xAI execution risks.

Near-term downside bias and elevated volatility risk as traders react to the first sell-side framing and implied drawdown.

Background

SpaceX debuted with a reported ~$75B IPO raise and closed its first session around a ~$2.1T market cap; the article frames this as a historic IPO and then pivots to the first sell-side rating.

Why it matters

The newest concrete fact is CFRA’s first sell rating issued minutes after first trade, with a $115 target implying up to ~29% downside from the first-day close; the thesis centers on Starship execution/delay risk and xAI growth/valuation sustainability concerns.

Market relevance

Traders may use the initiation target and stated risks as a near-term sentiment/positioning input for the IPO’s first days, especially given the large implied downside.

Market effects

Could temper enthusiasm for high-multiple, AI/space-adjacent IPOs by highlighting execution and valuation skepticism early in the listing cycle.

Limited direct regional impact; primarily affects US IPO/tech sentiment and Nasdaq trading flows.

Mostly US-focused sentiment signal; global relevance is secondary unless it triggers broader sell-side repricing of space/AI IPO cohorts.

Alternative perspectives

Early sell ratings can be contrarian and may be overwhelmed if the market continues to price SpaceX on long-duration optionality rather than near-term execution risk.

The article emphasizes Starship and xAI risks but does not provide new operational data; traders may instead focus on post-IPO liquidity, lockup expectations, and broader AI/space momentum.

Key entities

  • SpaceX

    Subject of the article; received its first Wall Street sell rating shortly after IPO trading began.

  • CFRA

    Issued the first sell rating and $115 price target cited in the article.

  • Keith Snyder

    CFRA analyst who initiated the sell rating and target.

Related articles

$SPCXMed

Beaten-down stock lets you buy SpaceX below market price

The article says Deutsche Bank initiated coverage of EchoStar (SATS) on July 7, framing it as a discounted way to own SpaceX. It cites a $143 price target and a claim that SATS offers about a 20% discount versus SpaceX. It notes EchoStar holds about $11 billion of SpaceX Class A shares, while EchoStar fell 23% since SpaceX’s IPO and is expected to report Q2 results July 30.

$SPCXMed

SpaceX Doubles Prices for Starlink Aviation Plans, Raises Hardware Cost to $200,000

Space Exploration Technologies (NASDAQ:SPCX) raised Starlink Business Aviation plan prices, according to a post on X. The Aviation Regional 25GB is $4,000/month (from $2,000), Regional Unlimited is $12,500/month, and Global Unlimited is $20,000/month (from $10,000). Starlink aviation hardware is $200,000 (from $145,000), with customer migration in August. Morgan Stanley cited a $600/share bull case.

$SPCXMed

SpaceX releases Grok 4.5, first model built alongside Cursor

SpaceX (NASDAQ:SPCX) released Grok 4.5, its first major AI model update built with Cursor for coding and agentic workflows. The 1.5T-parameter model was trained on tens of thousands of GB300 GPUs and follows Grok 4.3. SpaceX cites improved benchmark performance and lower pricing, $2 per 1M input tokens and $6 per 1M output. UBS reiterated a Buy and $210 target.

$SPCXMed

Elon Musk's Grok 4.5 Could Rewrite Enterprise AI Economics - SpaceX (NASDAQ:SPCX)

SpaceXAI, a wholly owned unit of Space Exploration Technologies Corp. (NASDAQ:SPCX), launched Grok 4.5 for coding and research-heavy tasks. The company says it is its strongest model and was trained alongside Cursor. Pricing is $2 per million input tokens and $6 per million output tokens, lower than Claude Opus 4.8, according to Counterpoint analyst Neil Shah. Shares were up 0.88% premarket at $149.60.

$SPCXMed

Jim Chanos Highlights Morgan Stanley's $672 Billion Funding Warning on Elon Musk's SpaceX - SpaceX (NASDA

Jim Chanos highlighted Morgan Stanley’s note on SpaceX’s funding needs, citing a multi-year external capital requirement of about $672 billion and no free-cash-flow positive period until 2035. Morgan Stanley kept an “Overweight” stance with a $300 price target, while warning SpaceX may need equity issuance or slower deployment if debt markets fail. SPCX listed June 12, 2026.